Filing Details
- Accession Number:
- 0001127602-13-010986
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-15 17:03:18
- Reporting Period:
- 2013-03-15
- Filing Date:
- 2013-03-15
- Accepted Time:
- 2013-03-15 17:03:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376545 | G Gordon Pugh | 852 Winter St. Waltham MA 02451 | Svp, Coo & Cro, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2013-03-15 | 4,502 | $23.09 | 9,833 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 5,000 | Indirect | Gordon G. Pugh Revocable Trust - 2012 |
Ordinary Shares | 15,000 | Indirect | Nancy E. Pugh Revocable Trust - 2012 |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.03 to $23.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.